Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-12 | Mr. Jean-Louis ChapdelaineIndependent Director | -25,00k | 276,02k | Derivative Exercise and Sale | 9,17 - 20,21 | 100,00k | - |
| 2026-05-13 | Mr. Peter A. DrutzLead Independent Director | -15,26k | 166,03k | Derivative Exercise and Sale | 9,18 - 20,06 | 104,99k | - |
| 2026-05-13 | Mr. Peter A. DrutzLead Independent Director | 9,74k | 89,41k | Derivative Exercise and Retained Stock | 9,18 | 104,99k | 10,22% |
| 2026-05-08 | Ms. Caroline BerubeIndependent Director | 25,00k | 229,74k | Derivative Exercise and Retained Stock | 9,19 | 25,00k | - |
| 2026-05-08 | Mr. Jean-Marie BourassaDirector | 75,00k | 714,43k | Derivative Exercise and Retained Stock | 9,19 - 9,69 | 256,82k | 41,25% |
| 2026-03-31 | Mr. Sylvain DumoulinIndependent Director | -5,00k | 94,92k | Verkauf | 18,98 | 105,00k | -4,55% |
| 2026-03-30 | Mr. Marcel BourassaExecutive Chairman of the Board | 97,00k | 1,83M | Kauf | 18,86 | 11,48M | 0,85% |
| 2026-03-27 | Mr. Marcel BourassaExecutive Chairman of the Board | 103,00k | 1,93M | Kauf | 18,76 | 11,06M | 0,94% |
| 2026-03-20 | Mr. Jean-Philippe De MontignyChief Transformation Officer | 2,72k | 50,50k | Kauf | 18,39 - 18,59 | 92,56k | 3,03% |
| 2026-03-20 | Mr. Sylvain DumoulinIndependent Director | 25,00k | 229,26k | Derivative Exercise and Retained Stock | 9,17 | 110,00k | 29,41% |
| 2026-03-13 | Mr. Jean-Philippe De MontignyChief Transformation Officer | 10,24k | 185,71k | Kauf | 18,14 | 89,84k | 12,86% |
| 2026-03-09 | Ms. Anne Le BretonIndependent Director | 4,14k | 73,54k | Kauf | 17,76 | 4,14k | - |
| 2026-03-06 | Mr. Sylvain AubryChief Legal Officer & Corporate Secretary | 18,27k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 19,39 | 136,61k | 15,44% |
| 2026-03-06 | Mr. Les TeagueGroup President of Patient Care | 17,88k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 19,39 | 87,88k | 25,54% |
| 2026-03-06 | Mr. Jean-Philippe De MontignyChief Transformation Officer | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 19,39 | 300,00k | 20,00% |
| 2026-03-06 | Mr. Sebastien BourassaPresident, CEO & Director | 25,00k | 203,04k | Derivative Exercise and Retained Stock | 8,12 | 413,55k | 6,43% |
| 2026-03-06 | Mr. Sebastien BourassaPresident, CEO & Director | 308,02k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 19,39 | 997,62k | 44,67% |
| 2026-03-06 | Mr. Stephen ReitknechtCFO | 24,80k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 19,39 | 224,80k | 12,40% |
| 2025-12-22 | Mr. Vince SciamannaPresident of Garaventa Lift Group N.A. & Garaventa Canada Ltd. | -20,00k | 174,33k | Derivative Exercise and Sale | 8,05 - 16,76 | 9,50k | - |
| 2025-11-14 | Mr. Les TeagueGroup President of Patient Care | -10,00k | 63,02k | Derivative Exercise and Sale | 9,61 - 15,91 | 0,00 | - |
| 2025-11-14 | Mr. Sylvain DumoulinIndependent Director | -10,00k | 160,48k | Verkauf | 16,05 | 85,00k | -10,53% |
| 2025-08-12 | Mr. Alexandre BourassaPresident of North America Accessibility | -25,00k | 183,95k | Derivative Exercise and Sale | 8,04 - 15,40 | 62,59k | - |
| 2025-08-08 | Patrick MongeauInsider | -16,67k | 69,42k | Derivative Exercise and Sale | 11,03 - 15,20 | 0,00 | - |
| 2025-08-08 | Mr. Sylvain AubryChief Legal Officer & Corporate Secretary | -13,33k | 202,71k | Verkauf | 15,20 | 4,62k | -74,26% |
| 2025-08-11 | Mr. Sylvain DumoulinIndependent Director | -5,00k | 76,16k | Verkauf | 15,23 | 95,00k | -5,00% |
| 2025-08-12 | Patrick MongeauInsider | -8,33k | 35,54k | Derivative Exercise and Sale | 11,03 - 15,30 | 0,00 | - |
| 2025-08-08 | Mr. Sylvain AubryChief Legal Officer & Corporate Secretary | 13,33k | 135,42k | Derivative Exercise and Retained Stock | 8,04 - 12,27 | 4,62k | -153,03% |
| 2025-08-08 | Patrick MongeauInsider | 8,33k | 125,34k | Derivative Exercise and Retained Stock | 15,04 | 0,00 | -100,00% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
